Fig. 1From: Demographics and clinical characteristics associated with sustained remission and continuation of sustained remission in patients with rheumatoid arthritis treated with adalimumabThe clinical course of patients who continued sustained remission and those who experienced RA flare. At all three points, disease activity were significantly reduced from baseline. (P value < 0.0001, one-way ANOVA test)Back to article page